Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Read original article on Health & Medicine News -- ScienceDaily →Related news
-
Most labs testing children for cardiac troponin lack pediatric reference ranges, survey finds
-
What Is the Pyro Method? How Celebrity Trainer Kirsty Godso Builds Functional Strength
-
The circumstances you grow up in are linked to how long you live
-
Radiation exposure linked to pulmonary hypertension after lung cancer treatment
-
A healthy Nordic diet may help you to live longer, but liver benefits remain unclear
-
The medicine of the future could be driven by mechanical cell memory
-
New genetic candidates help explain why autism affects males more often than females
-
I Solved My Runner’s Knee After Discovering Two Risk Factors I Couldn’t Change